Innovations in Cancer Treatment and Predictive Modeling Capture 2018 Wells and Kuzneski Competitions

Posted by & filed under Uncategorized .

A year ago the Food and Drug Administration (FDA) approved the first gene therapy in the U.S. The drug, Kymyriah, from pharmaceutical company Novartis, is a type of immunotherapy called chimeric antigen receptor (CAR) T cell therapy. It was approved to treat acute lymphoblastic leukemia, a cancer of the blood. It works by drawing blood… Read more »